Published December 2006 | Version Supplemental Material
Journal Article Open

Early frontotemporal dementia targets neurons unique to apes and humans

  • 1. ROR icon University of California, San Francisco
  • 2. ROR icon California Institute of Technology

Abstract

Objective: Frontotemporal dementia (FTD) is a neurodegenerative disease that erodes uniquely human aspects of social behavior and emotion. The illness features a characteristic pattern of early injury to anterior cingulate and frontoinsular cortex. These regions, though often considered ancient in phylogeny, are the exclusive homes to the von Economo neuron (VEN), a large bipolar projection neuron found only in great apes and humans. Despite progress toward understanding the genetic and molecular bases of FTD, no class of selectively vulnerable neurons has been identified. Methods: Using unbiased stereology, we quantified anterior cingulate VENs and neighboring Layer 5 neurons in FTD (n = 7), Alzheimer's disease (n = 5), and age‐matched nonneurological control subjects (n = 7). Neuronal morphology and immunohistochemical staining patterns provided further information about VEN susceptibility. Results: FTD was associated with early, severe, and selective VEN losses, including a 74% reduction in VENs per section compared with control subjects. VEN dropout was not attributable to general neuronal loss and was seen across FTD pathological subtypes. Surviving VENs were often dysmorphic, with pathological tau protein accumulation in Pick's disease. In contrast, patients with Alzheimer's disease showed normal VEN counts and morphology despite extensive local neurofibrillary pathology. Interpretation: VEN loss links FTD to its signature regional pattern. The findings suggest a new framework for understanding how evolution may have rendered the human brain vulnerable to specific forms of degenerative illness.

Additional Information

© 2006 American Neurological Association. Received Nov 10, 2006, and in revised form Nov 14. Accepted for publication Nov 14, 2006. This work was supported by the NIH (National Institute on Aging, K08 AG027086‐01, W.W.S.; P01 AG19724‐01A1, B.L.M.; P50 AG1657303‐75271, S.J.D., B.L.M.), the Larry L. Hillblom Foundation (2005/2T, W.W.S.), Doris Duke Foundation (D.A.C.), and the Gordon and Betty Moore Foundation and David and Lucile Packard Foundation (J.M.A.). The University of California at Irvine Alzheimer's Disease Research Center Neuropathology Core is supported by funding from NIH/NIA P50A916573 and the Institute for Brain Aging and Dementia Tissue Resource is supported by NIH/NIA PO14600538. We thank E. Head, J. Kaufman, K. Watson, E. Huang, J. Johnson, M. Sattavat, and J. Neuhaus for assistance and E. Roberson and H. Slama for comments on the manuscript. Finally, we thank our patients and their families for participating in dementia research.

Attached Files

Supplemental Material - jws-ana.21055.doc

Files

Files (103.4 kB)

Name Size
md5:1a5af44cfd0b4a46f3ec76914505c609
103.4 kB Download

Additional details

Identifiers

Eprint ID
106400
Resolver ID
CaltechAUTHORS:20201103-124307200

Funding

NIH
K08 AG027086-01
NIH
P01 AG19724-01A1
NIH
P50 AG1657303-75271
Larry L. Hillblom Foundation
Doris Duke Foundation
Gordon and Betty Moore Foundation
David and Lucile Packard Foundation
NIH
P50A916573
NIH
PO14600538

Dates

Created
2020-11-04
Created from EPrint's datestamp field
Updated
2021-11-16
Created from EPrint's last_modified field